Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

853
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

766
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
766
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS Cohort.

Annals of the American Thoracic Society·2026
Same author

Inhaler Technique in Chronic Obstructive Pulmonary Disease: Patient Impairments and Bronchodilation.

Annals of the American Thoracic Society·2026
Same author

ASO Visual Abstract: Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms.

Annals of surgical oncology·2026
Same author

New Consensus Statements for Peritoneal Surface Malignancy.

Annals of surgical oncology·2026
Same author

Development and Validation of an Electronic Health Record Algorithm to Predict the Presence of Chronic Obstructive Pulmonary Disease.

International journal of chronic obstructive pulmonary disease·2026
Same author

Enhancing Patient Lymphocyte Response to Peritoneal Malignancies Using a Personalized Immunocompetent Microfluidic Co-Culture Platform.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Apr 16, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Changing pattern in malignant mesothelioma survival.

Jennifer Faig1, Suzanne Howard2, Edward A Levine3

  • 1Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.

Translational Oncology
|March 10, 2015
PubMed
Summary
This summary is machine-generated.

Mesothelioma survival is poor, but peritoneal mesothelioma shows better survival than pleural mesothelioma. Non-occupational asbestos exposure is linked to peritoneal mesothelioma, highlighting exposure history for diagnosis.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.8K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Related Experiment Videos

Last Updated: Apr 16, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.8K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Area of Science:

  • Oncology
  • Epidemiology
  • Environmental Health

Background:

  • Mesothelioma survival rates are historically poor, with limited improvements.
  • Therapeutic impacts may vary by mesothelioma location (pleural vs. peritoneal).
  • Conflicting data exist on asbestos exposure's effect on mesothelioma location.

Purpose of the Study:

  • To analyze survival in a large mesothelioma cohort.
  • To examine survival based on tumor location and asbestos exposure details.

Main Methods:

  • Analysis of 380 mesothelioma cases diagnosed between 1992 and 2012.
  • Data collected via questionnaires, physician interviews, and medical record reviews.
  • Inclusion of cases from treatment referrals, medical-legal evaluations, and volunteers.

Main Results:

  • This study indicates improved mesothelioma survival compared to historical data.
  • Peritoneal mesothelioma demonstrated significantly longer survival than pleural mesothelioma (HR=0.36, p<.001).
  • Non-occupational cases were more frequently peritoneal, female, exposed, younger at diagnosis, and had shorter latency.

Conclusions:

  • Peritoneal mesothelioma is more frequently associated with non-occupational asbestos exposure.
  • Emphasis on detailed exposure history is crucial for early diagnosis and improved treatment outcomes.
  • Findings underscore the importance of considering exposure source in mesothelioma management.